Skip to main content
Watch Insiders
SYRE filings

Corporate insider profile

Scott L Burrows Filing Activity

Latest reported as Chief Financial Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,106,872.50
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$95.57$716,771
Jul 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$87.74$658,040
Jun 25, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale15,000$87.13$1,307,000
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium